Eric B. Meltzer

1.5k total citations · 1 hit paper
12 papers, 1.1k citations indexed

About

Eric B. Meltzer is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Eric B. Meltzer has authored 12 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Eric B. Meltzer's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers) and Pulmonary Hypertension Research and Treatments (2 papers). Eric B. Meltzer is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers) and Pulmonary Hypertension Research and Treatments (2 papers). Eric B. Meltzer collaborates with scholars based in United States, China and Denmark. Eric B. Meltzer's co-authors include Paul W. Noble, Yuejuan Li, Jiurong Liang, Dianhua Jiang, Yu Yamaguchi, Alice Gray, Lise Wogensen, Ting Xie, Lake Morrison and Andrew M. Tager and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Eric B. Meltzer

12 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study

2023 82 citations Steven M. Rowe, Jonathan B. Zuckerman et al. Journal of Cystic Fibrosis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric B. Meltzer United States	9	685	285	145	134	117	12	1.1k
K. Zhang United States	6	416 0.6×	268 0.9×	169 1.2×	86 0.6×	127 1.1×	9	955
J. Marchal-Sommé France	20	799 1.2×	420 1.5×	138 1.0×	146 1.1×	64 0.5×	29	1.4k
Ningshan Liu United States	17	856 1.2×	551 1.9×	211 1.5×	106 0.8×	115 1.0×	22	1.5k
Gavin Tjin Australia	15	339 0.5×	224 0.8×	121 0.8×	160 1.2×	76 0.6×	20	797
R.M. duBois United Kingdom	14	962 1.4×	161 0.6×	90 0.6×	291 2.2×	70 0.6×	16	1.3k
Guanchao Jiang China	18	382 0.6×	508 1.8×	151 1.0×	127 0.9×	34 0.3×	75	1.2k
Bridget McGarry United States	13	686 1.0×	201 0.7×	97 0.7×	200 1.5×	31 0.3×	15	1.1k
Mareike Lehmann Germany	19	879 1.3×	480 1.7×	247 1.7×	200 1.5×	38 0.3×	47	1.5k
Mauricio Rojas United States	17	780 1.1×	341 1.2×	153 1.1×	190 1.4×	32 0.3×	34	1.3k
Susan Mathai United States	19	684 1.0×	231 0.8×	62 0.4×	183 1.4×	37 0.3×	38	1.1k

Countries citing papers authored by Eric B. Meltzer

Since Specialization

Citations

This map shows the geographic impact of Eric B. Meltzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric B. Meltzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric B. Meltzer more than expected).

Fields of papers citing papers by Eric B. Meltzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric B. Meltzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric B. Meltzer. The network helps show where Eric B. Meltzer may publish in the future.

Co-authorship network of co-authors of Eric B. Meltzer

This figure shows the co-authorship network connecting the top 25 collaborators of Eric B. Meltzer. A scholar is included among the top collaborators of Eric B. Meltzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric B. Meltzer. Eric B. Meltzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Rowe, Steven M., Jonathan B. Zuckerman, Daniel Dorgan, et al.. (2023). Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study. Journal of Cystic Fibrosis. 22(4). 656–664. 82 indexed citations breakdown →

Meltzer, Eric B., William T. Barry, Ivana V. Yang, et al.. (2014). Familial and sporadic idiopathic pulmonary fibrosis: making the diagnosis from peripheral blood. BMC Genomics. 15(1). 902–902. 4 indexed citations

Kelly, Francine L., Vanessa E. Kennedy, Raksha Jain, et al.. (2012). Epithelial Clara Cell Injury Occurs in Bronchiolitis Obliterans Syndrome After Human Lung Transplantation. American Journal of Transplantation. 12(11). 3076–3084. 46 indexed citations

Meltzer, Eric B., William T. Barry, Thomas A. D’Amico, et al.. (2011). Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle. BMC Medical Genomics. 4(1). 70–70. 86 indexed citations

Lovgren, Alysia Kern, Jeffrey J. Kovacs, Ting Xie, et al.. (2011). β-Arrestin Deficiency Protects Against Pulmonary Fibrosis in Mice and Prevents Fibroblast Invasion of Extracellular Matrix. Science Translational Medicine. 3(74). 74ra23–74ra23. 75 indexed citations

Li, Yuejuan, Dianhua Jiang, Jiurong Liang, et al.. (2011). Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. The Journal of Cell Biology. 194(1). i3–i3. 6 indexed citations

Li, Yuejuan, Dianhua Jiang, Jiurong Liang, et al.. (2011). Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. The Journal of Experimental Medicine. 208(7). 1459–1471. 302 indexed citations

Jiang, Dianhua, Jiurong Liang, Gabriele Campanella, et al.. (2010). Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4. Journal of Clinical Investigation. 120(6). 2049–2057. 129 indexed citations

Meltzer, Eric B. & Paul W. Noble. (2008). Idiopathic pulmonary fibrosis. Orphanet Journal of Rare Diseases. 3(1). 8–8. 317 indexed citations

10.

Sun, Lena S., David C. Adams, Ellise Delphin, et al.. (1997). Sympathetic response during cardiopulmonary bypass. Critical Care Medicine. 25(12). 1990–1993. 16 indexed citations

11.

Godfrey, S., et al.. (1972). Pulmonary embolism and the pickwick syndrome. British Journal of Diseases of the Chest. 66(2). 155–161. 3 indexed citations

12.

Meltzer, Eric B., et al.. (1967). A new look at ventricular tachycardia.. PubMed. 22(6). 519–35. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact